22/11/2023 Notice of Clinical Trial for Canine Intranasal Adenocarcinoma in the United States for FDA submission 15/09/2023 LAVURCHIN® Receives Japanese Pharmaceutical Regulatory Approval as a Radiosensitizer for Dogs 28/03/2019 Site renewal implemented.
